Search

Your search keyword '"ALPHAVIRUSES"' showing total 2,545 results

Search Constraints

Start Over You searched for: Descriptor "ALPHAVIRUSES" Remove constraint Descriptor: "ALPHAVIRUSES"
2,545 results on '"ALPHAVIRUSES"'

Search Results

1. Distinct chikungunya virus polymerase palm subdomains contribute to viral protein accumulation and virion production.

2. How structural biology has changed our understanding of icosahedral viruses.

3. Hepatitis B Surface Antigen Loss: What Does Integration Have to Do With a Functional Hepatitis B Virus Cure?

4. Antibodies against medically relevant arthropod-borne viruses in the ubiquitous African rodent Mastomys natalensis.

5. Detection of two alphaviruses: Middelburg virus and Sindbis virus from enzootic amplification cycles in southwestern Uganda.

6. ESCRT Protein VPS4A Is Required for the Formation of Replication Centers and Replication of Human Coronavirus 229E (HCoV-229E).

7. The First Isolation of Insect-Specific Alphavirus (Agua Salud alphavirus) in Culex (Melanoconion) Mosquitoes in the Brazilian Amazon.

8. Sedentary behavior, increasing age, and overweight/obesity increase the presence and intensity of the chronic joint pain in individuals affected by Chikungunya fever.

9. Nonreciprocity in CHIKV and MAYV Vaccine-Elicited Protection.

10. Unraveling the complex interplay: immunopathology and immune evasion strategies of alphaviruses with emphasis on neurological implications.

11. The persistence of SARS-CoV-2 in tissues and its association with long COVID symptoms: a cross-sectional cohort study in China.

12. The Approved Live-Attenuated Chikungunya Virus Vaccine (IXCHIQ ®) Elicits Cross-Neutralizing Antibody Breadth Extending to Multiple Arthritogenic Alphaviruses Similar to the Antibody Breadth Following Natural Infection.

13. Systemic and Ocular Manifestations of Arboviral Infections: A Review.

14. Safety and immunogenicity of the live-attenuated hRVFV-4s vaccine against Rift Valley fever in healthy adults: a dose-escalation, placebo-controlled, first-in-human, phase 1 randomised clinical trial.

15. Comparative analysis of the taxonomic classification criteria for a number of groups of pathogenic DNA and RNA viruses based on genomic data

16. A prM mutation that attenuates dengue virus replication in human cells enhances midgut infection in mosquitoes.

17. The evolutionary and molecular history of a chikungunya virus outbreak lineage.

18. Utility of SARS-CoV-2 Subgenomic RNA in Kidney Transplant Recipients Receiving Remdesivir.

19. Changes in the chikungunya virus E1 glycoprotein domain II and hinge influence E2 conformation, infectivity, and virusreceptor interactions.

20. An improved alphaviruses‐specific RT‐qPCR facilitates monitoring and prevention of alphaviruses.

21. Co-circulation of two Alphaviruses in Burkina Faso: Chikungunya and O'nyong nyong viruses.

22. LDL receptor in alphavirus entry: structural analysis and implications for antiviral therapy.

23. Clinical outcomes of chikungunya: A systematic literature review and meta-analysis.

24. Research trends on alphavirus receptors: a bibliometric analysis.

25. Characterisation of sRNAs enriched in outer membrane vesicles of pathogenic Flavobacterium psychrophilum causing Bacterial Cold Water Disease in rainbow trout.

26. Elucidation of the Epitranscriptomic RNA Modification Landscape of Chikungunya Virus.

27. Advances in Alphavirus and Flavivirus Research.

28. Syrian Hamsters Model Does Not Reflect Human-like Disease after Aerosol Exposure to Encephalitic Alphaviruses.

30. Vertical transmission of SARS-CoV-2 delta-variant in a preterm infant.

31. Effectiveness of structured Behavior Change Communication methods in control of mosquito-borne diseases: A quasi-experimental study.

32. Bovine astrovirus and its role in lymphocytic encephalitis in cattle in Ontario, Canada, 1988–2019.

34. Recurrent Loss of Macrodomain Activity in Host Immunity and Viral Proteins

35. Live-attenuated CHIKV vaccine with rearranged genome replicates in vitro and induces immune response in mice.

36. Role of microRNAs in host defense against porcine reproductive and respiratory syndrome virus infection: a hidden front line.

37. Trans-Amplifying RNA: A Journey from Alphavirus Research to Future Vaccines.

38. Sindbis Virus Vaccine Platform: A Promising Oncolytic Virus-Mediated Approach for Ovarian Cancer Treatment.

39. A role for tunneling nanotubes in virus spread.

40. Translational Control of Alphavirus–Host Interactions: Implications in Viral Evolution, Tropism and Antiviral Response.

41. The many ways in which alphaviruses bind to cells.

42. Viral agents (2nd section).

43. Cytomegalovirus Colitis and Colon Adenocarcinoma: A Case of Unusual Co-existence.

44. Serosurvey of Chikungunya Virus in Old World Fruit Bats, Senegal, 2020--2022.

45. GBP1, an interferon‐inducible GTPase, inhibits Hantaan viral entry by restricting clathrin‐mediated endocytosis.

46. Nonreciprocity in CHIKV and MAYV Vaccine-Elicited Protection

47. The Approved Live-Attenuated Chikungunya Virus Vaccine (IXCHIQ®) Elicits Cross-Neutralizing Antibody Breadth Extending to Multiple Arthritogenic Alphaviruses Similar to the Antibody Breadth Following Natural Infection

48. Updating estimates of Plasmodium knowlesi malaria risk in response to changing land use patterns across Southeast Asia.

49. LDLR is used as a cell entry receptor by multiple alphaviruses.

50. Differential susceptibility of human microglia HMC3 cells and brain microvascular endothelial HBEC-5i cells to Mayaro and Una virus infection.

Catalog

Books, media, physical & digital resources